Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice T Shaw

Showing results (21-30 of 204) with videos related to

Pageof 21
Sort By:
The Lancet. Oncology|December 10, 2016
Raising the bar on first-line immunotherapy in lung cancerJessica J Lin, Alice T Shaw
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategiesChristine M Lovly, Alice T Shaw
Nature Medicine|February 6, 2020
Resistance looms for KRAS<sup>G12C</sup> inhibitorsAaron N Hata, Alice T Shaw
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2017
Recent Advances in Targeting ROS1 in Lung CancerJessica J Lin, Alice T Shaw
The New England Journal of Medicine|February 12, 2015
Crizotinib in ROS1-rearranged non-small-cell lung cancerAlice T Shaw, Benjamin J Solomon
The Oncologist|June 2, 2016
Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?Ibiayi Dagogo-Jack, Alice T Shaw
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2017
Expanding the Roster of ROS1 InhibitorsIbiayi Dagogo-Jack, Alice T Shaw
Cell|May 20, 2017
Lung Cancer: A Wily Genetic OpponentPeggy P Hsu, Alice T Shaw
Trends in Cancer|November 8, 2016
Resisting Resistance: Targeted Therapies in Lung CancerJessica J Lin, Alice T Shaw
Nature Reviews. Drug Discovery|December 2, 2011
CrizotinibAlice T Shaw, Uma Yasothan, Peter Kirkpatrick
Pageof 21

Showing results (21-30 of 204) with videos related to

Sort By:
Pageof 21
The Lancet. Oncology|December 10, 2016
Raising the bar on first-line immunotherapy in lung cancerJessica J Lin, Alice T Shaw
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategiesChristine M Lovly, Alice T Shaw
Nature Medicine|February 6, 2020
Resistance looms for KRAS<sup>G12C</sup> inhibitorsAaron N Hata, Alice T Shaw
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2017
Recent Advances in Targeting ROS1 in Lung CancerJessica J Lin, Alice T Shaw
The New England Journal of Medicine|February 12, 2015
Crizotinib in ROS1-rearranged non-small-cell lung cancerAlice T Shaw, Benjamin J Solomon
The Oncologist|June 2, 2016
Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?Ibiayi Dagogo-Jack, Alice T Shaw
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2017
Expanding the Roster of ROS1 InhibitorsIbiayi Dagogo-Jack, Alice T Shaw
Cell|May 20, 2017
Lung Cancer: A Wily Genetic OpponentPeggy P Hsu, Alice T Shaw
Trends in Cancer|November 8, 2016
Resisting Resistance: Targeted Therapies in Lung CancerJessica J Lin, Alice T Shaw
Nature Reviews. Drug Discovery|December 2, 2011
CrizotinibAlice T Shaw, Uma Yasothan, Peter Kirkpatrick
Pageof 21